Elon Musk’s brain-implant startup received approval from the Food and Drug Administration to conduct clinical trials of its experimental device in humans.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” Neuralink said Thursday in a tweet. Neuralink continued, “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.” We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our… — Neuralink (@neuralink) May 25, 2023 Musk retweeted the post, congratulating Neuralink. Congratulations Neuralink team! https://t.co/AWZGf33UDr — Elon Musk (@elonmusk) May […]
Read the Whole Article From the Source: www.zerohedge.com